期刊文献+

精神分裂症患者伴发代谢综合征的相关因素分析 被引量:3

Analysis of the Related Factors of the Prevalence of Metabolic Syndrome in Schizophrenia Patients
在线阅读 下载PDF
导出
摘要 [目的]了解住院精神分裂症患者中代谢综合征发生率及其相关因素.[方法]对广州市精神病医院住院6个月或以上的精神分裂症患者记录一般人口学资料、病史、服药情况,测量其体重、身高、腹围,测定血糖、血脂及血压指标.对其伴发代谢综合征发生率及其相关因素进行分析.[结果]住院精神分裂症患者伴代谢综合征发生率为36.8%,女性发生率(50.7%)较男性(29.3%)高(χ2=18.21,P<0.01).女性患者糖脂代谢异常的比例较男性高.Logistic回归显示性别因素与代谢综合征的发生有关(P<0.01).[结论]在长期住院的精神分裂症患者中,女性患者伴代谢综合征发生率较高,需加以关注. [Objective]To investigate the prevalence of metabolic syndrome in schizophrenia inpatients and its relative factors. [Methods] All subjects were inpatients diagnosed with schizophrenia in Guangzhou Psychiatry Hospital for more than 6 months. Demographic information, case history and medication condition were recorded. The weight, height, abdominal circumference, blood glucose and blood lipid were measured. The prevalence of metabolic syndrome in schizophrenia and its relative factors were analyzed. [Results] The preva lence of metabolic syndrome in schizophrenia was 36.8% and it was higher in female patients than that in male patients(50.7% vs 29.3%,X2=18.21, P〈0.01). The prevalence of glucose and lipid metabolism ab normality was higher in female patients than that in male patients. Logistic regression analysis showed that the gender was related with the incidence of metabolic syndrome( P〈0.01). [Conclusion]Metabolic syndrome occurs in long term schizophrenia inpatients, especially in female patients. It should be paid attention.
出处 《医学临床研究》 CAS 2011年第2期217-219,共3页 Journal of Clinical Research
基金 广州市医药卫生科技项目(编号:201102A213183)
关键词 精神分裂症/并发症 代谢疾病/并发症 综合征 schizophrenia/CO metabolic diseases/CO syndrome
  • 相关文献

参考文献7

  • 1McEvoy JP, Meyer JM, Goff DC, et al . Prevalence of the metabolic syndrome in patients with schizophrenia=baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CAT1E) schizophrenia trial and comparison with national estimates from NHANES m [J]. Schizophr Res ,2005,80(1): 19-32.
  • 2Alberti KG, Zimmet P, Shaw J. The metabolic syndrome--a new worldwide definition[J]. Lancet ,2005,366(9491): 1059-1062.
  • 3Koponen HJ, Hakko HH, Saari KM, et al. The prevalence and predictive value of individual criteria {or metabolic syn-drome in schizophrenia a Northern Finland 1966 Birth Cohort Study[J]. World J Biol Psychiatry , 2010,11 (2Pt2) : 262-267.
  • 4刘燕,李华芳,焦玉梅,王佩青,钱竹书.住院精神分裂症患者代谢综合征的患病率及相关因素[J].上海精神医学,2009,21(1):16-19. 被引量:26
  • 5Brunero S, Lamont S, Fairbrother G. Prevalence and predic-tors of metabolic syndrome among patients attending an outpa-tient elozapine clinic in Australia[J]. Arch Psychiatr Nurs , 2009,23(3):261-268.
  • 6Regitz Zagrosek V, Lehmkuhl E, Weickert MO. Gender Jifferences in the metabolic syndrome and their role for eardio-cascular disease[J]. CLin Res Cardiol ,2006,95(3): 136-147.
  • 7Wu RR, Zhao JP, Zhai JG, et al . Sex difference in effects of typical and atypical antipsycbotics on glucose-insulin homeo-stasis and lipid metabolism in first-episode schizophrenia[J]. J Chin Psychopharmacol ,2007,27(4) : 374-379.

二级参考文献18

  • 1Newcomer JW. Metabolic considerations in the use of antipsychotic medications : a review of recent evidence. J Clin Psychiat, 2007, 68(Suppl) :20-27.
  • 2Alberti KG, Zimmet P, Shaw J, for the IDF Epidemiology Task Force Consensus Group. The metabolic syndrome: a new worldwide definition. Lancet, 2005, 366(949) : 1059 - 1062.
  • 3Saari K, Linddeman S, Viilo KM, et al. A 4 - fold risk of metabolic syndrome in patients with schizophrenia: the Northern Finland 1966 birth cohort study. J Clin Psychiat, 2005, 66(5) : 559 -563.
  • 4Heiskanen TH, Niskanen LK, Lyytikainen R, et al. Metabolic syndrome in patients with schizophrenia. J Clin Psychiat, 2003,64 (5) : 575 - 579.
  • 5Ford ES. Prevalence of/he metabolic syndrome defined by the International Diabetes Federation among adults in the US. Diabetes Care, 2005, 28( 11 ) , 2745 -2749.
  • 6Cohn T, Prud' homme D, Streiner D, et al. Characterizing coronary heart disease risk in chronic schizophrenia: high prevalence of the metabolic syndrome. Can J Psychiat, 2004, 49 ( 11 ) : 753 - 760.
  • 7Gu D, Reynolds K, Wu X, et al. Prevalence of the metabolic syndrome and overweight mnong adults in China. Lancet, 2005, 365 (9468) : 1398 - 1405.
  • 8Lu B, Yang Y, Song X, et al. An evaluation of the international diabetes federation definition of metabolic syndrome in Chinese patients older than 30 years and diagnosed with type 2 diabetes mellitus. Metabolism, 2006, 55(8): 1088- 1096.
  • 9Weng X, Liu Y, Ma J, el al. An urban - rural comparison of the prevalence of the metabolic syndrome in Eastern China. Public Health Nutr, 2007, 10(2) :131 - 136.
  • 10Tan CE, Ma S, Wai D, et al. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care, 2004 , 27 (5) : 1182 - 1186.

共引文献25

同被引文献29

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3070
  • 2Smieskova R, Marmy J, Schmidt A, et al. Do subjects at clinical high risk for psychosis differ from those with a genetic high risk? --A sys- tematic review of structural and functional brain abnormalities [ J ]. Curr Med Chem,2013,20(3) :467-481.
  • 3Gao S, Hu Z, Cheng J, et al. Impact of catechol-o-methyltransferase polymorphisms on risperidone treatment for schizophrenia and its po- tential clinical significance [ J]. Clin Biochem ,2012,45 ( 10-11 ) :787- 792.
  • 4Eisenberg DP, Sarpal D, Kohn PD, et al. Catechol-o-methyltransferase valine( 158 )methionine genotype and resting regional cerebral blood flow in medication-free patients with schizophrenia [ J ]. Biol Psychia- try, 2010,67 ( 3 ) : 287-290.
  • 5Sagud M, Muck-Seler D, Mihaljevic-Peles A, et al. Catechol-O-methyl transferase and schizophrenia [ J ]. Psychiatr Danub, 2010,22 ( 2 ) :270-274.
  • 6Wang Y, Fang Y, Shen Y, et al. Analysis of association between the catechol-O-methyltransferase(COMT) gene and negative sytnptoms in chronic schizophrenia[ J ]. Psychiatry Res, 2010,179 ( 2 ) : 147-150.
  • 7Gupta M, Bhatnagar P, Grover S, et al. Association studies of catechol- O-methyltransferase(COMT) gene with schizophrenia and response to antipsychntic treatment [ J ]. Pharmacogenomics, 2009,10 ( 3 ) : 385- 397.
  • 8Barnett JH, Heron J, Goldman D, et al. Effects of catechol-O-methyl- transferase on normal variation in the cognitive function of children [ J ]. Am J Psychiatry,2009,166 ( 8 ) :909-916.
  • 9Yasui-Furukori N, Saito M, Tsuchimine S, et al. Association between dopamine-related polymorphisms and plasma concentrations of prolac- tin during risperidone treatment in schizophrenic patients [ J ]. Prog Neuropsychopharmacol Biol Psychiatry ,2008,32 ( 6 ) : 1491-1495.
  • 10Komossa K,Rummel-Kluge C,Schwarz S. Olanzapine vetsus other atypical antipsychoties for schizophrenia[J].Co-chrane Database Syst Rev,2010,(3):654-656.

引证文献3

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部